Putting cows on the front page since 1885.
Alan J. Kivitz MD, founder of the Altoona Arthritis & Osteoporosis Center and the Altoona Center for Clinical Re- search, recently traveled to Israel where he gave several lectures and participated in several other Rheumatology events.
He presented a lecture titled “A Novel IL-6i treatment for RA-Clinical Practice” at three Israeli Rheumatology Centers in Petah Tikva and Tel Aviv. He also gave a presentation at the Israeli Annual Rheumatology Congress in Jerusalem titled “The Role of IL6 in the Pathogenesis of RA and Associated Co-Morbidities.” He took part in an advisory board discussion ”Smart Cycling in RA Management” and a question-and-answer session with Israeli Rheumatologists.
As a practicing physician, Dr. Kivitz has more than 36 years of experience treating patients with arthritis and rheumatic disorders. He received his medical degree from Albany (New York) Medical College. He completed training in internal medicine at the North Shore University Hospital in Manhasset, New York, and Memorial Sloan Kettering Cancer Center in New York City. Dr. Kivitz then completed his fellowship training in rheumatology at Albany Medical College. He is board certified in internal medicine as well as the subspecialty of rheumatology.
Dr. Kivitz has authored and co-authored more than 500 research articles, abstracts, and studies on subjects covering osteoarthritis, osteoporosis, rheumatoid arthritis, and pain management. In addition, his studies have been published in several prestigious medical journals including The New England Journal of Medicine, Pain Medicine, Journal of the American Medical Association, Arthritis & Rheumatology, and Journal of Clinical Rheumatology. Dr. Kivitz has served as a consultant on numerous osteoarthritis and rheumatoid arthritis clinical trials.
Dr. Kivitz has served as a member of advisory boards and speaker bureaus for Abbvie, Amgen, Bristol-Myers Squibb, Celgene, Crescendo Bioscience, Genentech, GlaxoSmithKline, Horizon, Janssen, Pfizer, Regeneron Pharmaceuticals, Sanofi-Genzyme, Takeda, and UCB. Dr. Kivitz has assisted in the design of clinical trial protocols of more than 10 Pharmaceutical companies.
Dr. Kivitz is an active member of the Pennsylvania Medical Society and the American Medical Association. He holds certifications in Human Subjects Protection and HIPAA Research Training and is classified as a certified principal investigator by the Association of Clinical Research Professionals. His research work has focused on the development of newer strategies for treating patients with arthritis and rheumatic disorders.
He has served as Principal Investigator or Sub-investigator in more than 1000 clinical trials.
Reader Comments(0)